News & Insights | Informa Connect

This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Model risk management in the age of AI

Understanding the benefits of alternative ETFs in investment portfolios

Poll results: The QuantMinds community’s thoughts on the state of quant finance

MMS buys Exploristics for modeling tech and expanded reach

Report cards and incentives promote transparency in drug trials, analysis says

Fortrea hired to help prep disease detection AI for FDA review

Sofinnova and Medicxi talk M&A, patent cliffs, and China

EBD Group Celebrates 30 Years of Facilitating Deal-Making in Life Sciences

Why Milan Punches Above Its Weight For Biotech Partnering

BIO-Europe® 2024 is going to Stockholm

EBD Group’s BIO-Europe event celebrates its 30th anniversary

Adjusted for Risk: The Business Case for Pro Bono Financial Planning

Private equity vs. private credit: Where are the markets headed?

How are top GPs winning in a tough fundraising market? With Mina Nazemi, Barings

Unfiltered: Attendees reveal the hype behind SuperReturn North America

Where there's VC there's a way: The future of venture capital in Saudi Arabia

Staying ahead of the healthcare curve: Opportunities for investment in Saudi Arabia

Specialty Therapies and Field Reimbursement Services: Driving Better Outcomes for Brands and Patients

Guiding AI in plain language summaries for clinical trial results

Alimentiv and PhaseV to use machine learning for GI-focused drug trials

Quick Links